Effective long-term control of cardiac events with β-blockers in a family with a common LQT1 mutation

Clinical Genetics

Volumn 65, Issue 3, 2004, Pages 233-241

  Wedekind, Horst ^a   Schwarz, M ^a   Hauenschild, S ^b   Djonlagic, H ^c   Haverkamp, W ^d   Breithardt, G ^a   Wulfing T ^a   Pongs, O ^b   Isbrandt, D ^b   Schulze Bahr, E ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

blocker; Long QT syndrome; Mutation; Sudden death; Ventricular arrhythmias

Indexed keywords

AMINO ACID; AMITRIPTYLINE; ANKYRIN; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; DNA; POTASSIUM; POTASSIUM CHANNEL KCNQ1; PRIMIDONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; FAMILIAL DISEASE; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC VARIABILITY; HEART DISEASE; HETEROZYGOTE; HUMAN; LONG QT SYNDROME; LONG TERM CARE; MALE; MYOCLONUS EPILEPSY; NONHUMAN; OOCYTE; PHYSICIAN; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; RECORDING; SUDDEN DEATH; SYMPTOMATOLOGY; VOLTAGE CLAMP; XENOPUS;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANIMALS; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGY; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; HUMANS; KCNQ POTASSIUM CHANNELS; KCNQ1 POTASSIUM CHANNEL; MALE; MIDDLE AGED; MUTATION, MISSENSE; OOCYTES; PEDIGREE; PHENOTYPE; POTASSIUM CHANNELS, VOLTAGE-GATED; ROMANO-WARD SYNDROME; XENOPUS;

EID: 10744224917     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0009-9163.2004.00221.x     Document Type: Article

References (33)

1. Lübbers P. Das erbliche Syndrom der QT-Verlängerung mit synkopalen Anfällen. Z Kreislaufforsch 1972: 61: 907-918.
2. Wang Q, Curran ME, Splawski I et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996: 12: 17-23.
3. Wang Q, Shen J, Splawski I et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995: 80: 805-811.
4. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmias: HERG mutations cause long QT syndrome. Cell 1995: 80: 795-803.
5. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress Iks function. Nat Genet 1997: 17: 338-340.
6. Abbott GW, Sesti F, Splawski I et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999: 3: 175-187.
7. Plaster NM, Tawil R, Tristani-Firouzi M et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001: 105: 511-519.
8. Mohler PJ, Schott JJ, Gramolini AO et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003: 421: 634-639.
9. Wilde AAM, Escande D. LQT genotype-phenotype relationships: patients and patches. Cardiovasc Res 2001: 51: 627-629.
10. Priori SG, Napolitano C, Schwartz P. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999: 2: 529-533.
11. Locati EH, Zareba W, Moss AJ et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 1998: 97: 2237-2244.
12. Bazett AM. An analysis of the time-relations of electrocardiograms. Heart 1920: 7: 353-369.
13. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993: 88: 782-784.
14. Higuchi R. Simple and rapid preparation of samples for PCR. In: PCR-Technology: Principles and Applications for DNA Amplification (Ehrlich HA, ed). New York: Stockton Press, 1989: 31-38.
15. Schulze-Bahr E, Schwarz M, Hauenschild S et al. A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype. J Mol Med 2001: 79: 504-509.
16. Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT. Genomic structure of three long QT syndrome genes: KCNQ1, HERG, and KCNE1 Genomics 1998: 51: 86-97.
17. Rust S, Funke H, Assmann G. Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Res 1993: 21: 3623-3629.
18. Schmitt N, Schwarz M, Peretz A, Abitbol I, Attali B, Pongs O. A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly. EMBO J 2000: 19: 332-340.
19. Zhang L, Timothy KW, Vincent GM et al. Spectrum of ST-T wave patterns and repolarization parameters in congenital long QT syndrome-ECG findings identify genotypes. Circulation 2000: 102: 2849-2855.
20. Wedekind H, Schulze-Bahr E, Djonlagic H. Postextrasystolic 'T wave hump' augmentation as a marker of increased arrhythmogenic risk in the long QT syndrome. Heart 2002: 88: 633.
21. Ks potassium channel. Nature 1996: 384: 80-83.
22. Lande G, Kyndt F, Baro I et al. Dynamic analysis of the QT interval in long QTI syndrome patients with a normal pheno-type. Eur Heart J 2001: 22: 410-422.
23. van den Berg MP, Wilde AA, Viersma TJW et al. Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol 2001: 12: 630-636.
24. Donger C, Denjoy 1, Berthet M et al. KCNQ1 C-terminal missense mutation causes a forme fruste long QT syndrome. Circulation 1997: 96: 2778-2781.
25. Wang Z, Tristani-Firouzi M, Xu Q, Lin M, Keating MT, Sanguinetti MC. Functional effects of mutations in KvLQT1 that cause long QT syndrome. J Cardiovasc Electrophysiol 1999: 10: 817-826.
26. Paulussen A, Matthijs G, Gewillig M, Verhasselt P, Cohen N, Aerssens J. Mutation analysis in congenital long QT syndrome - a case with missense mutations in KCNQ1 and SCN5A. Genet Test 2003: 7: 57-61.
27. Moss AJ, Zareba W, Hall WJ et al. Effectiveness and limitations of β-blocker therapy in congenital long-QT syndrome. Circulation 2000: 101: 616-623.
28. Shimizu W, Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome. Circulation 1998: 98: 2314-2322.
29. Vincent GM, Jaiswal D, Timothy KW. Effects of exercise on heart rate, QT, QTc and QT/QS2 in the Romano-Ward inherited long QT syndrome. Am J Cardiol 1991: 68: 498-503.
30. Schwartz PJ, Priori SG, Spazzolini C et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythimas. Circulation 2001: 103: 89-95.
31. Chen S, Zhang L, Bryant RM et al. KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death. Clin Genet 2003: 63: 273-282.
32. Haverkamp W, Mönnig G, Eckardt L et al. Acquired abnormal QT prolongation and torsade de pointes - clinical significance of genetic information from congenital long QT syndrome. In: From Molecule to Men. Molecular Basis of Congenital Cardiovascular Disorders (Zehender M, Breithardt G, Just H, eds). Darmstadt: Steinkopff; New York: Springer, 2000: 99-111.
33. Davison ET. Amitriptyline-induced torsade de pointes. Successful therapy with atrial pacing. J Electrocardiol 1985: 18: 299-301.